These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9704661)

  • 1. von Willebrand disease: recent advances in pathophysiology and treatment.
    Phillips MD; Santhouse A
    Am J Med Sci; 1998 Aug; 316(2):77-86. PubMed ID: 9704661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of inherited von Willebrand disease in 2007.
    Federici AB; Mannucci PM
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the diagnosis and management of von Willebrand disease.
    Franchini M
    Hematology; 2006 Aug; 11(4):219-25. PubMed ID: 17178659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perioperative therapy of von Willebrand disease. Demonstration of pathophysiology, clinical problems and therapy options using two case reports].
    Kleinschmidt S; Fuchs-Buder T; Wilhelm W; Seyfert UT; Mörsdorf S
    Anaesthesist; 2002 Oct; 51(10):825-34. PubMed ID: 12395174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 von Willebrand disease: application of emerging data to clinical practice.
    Collins PW; Cumming AM; Goodeve AC; Lillicrap D
    Haemophilia; 2008 Jul; 14(4):685-96. PubMed ID: 18510569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.
    Rodeghiero F; Castaman G; Tosetto A
    Hematology Am Soc Hematol Educ Program; 2009; ():113-23. PubMed ID: 20008189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand disease: pathogenesis, classification, and management.
    Murray EW; Lillicrap D
    Transfus Med Rev; 1996 Apr; 10(2):93-110. PubMed ID: 8721967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
    Franchini M; Mannucci PM
    Expert Rev Hematol; 2016 Sep; 9(9):825-30. PubMed ID: 27427955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.
    Lillicrap D
    Blood; 2013 Nov; 122(23):3735-40. PubMed ID: 24065240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired von Willebrand syndrome: an update.
    Franchini M; Lippi G
    Am J Hematol; 2007 May; 82(5):368-75. PubMed ID: 17133419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB
    Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiology of von Willebrand disease: therapeutic implications.
    Schneppenheim R
    Thromb Res; 2011; 128 Suppl 1():S3-7. PubMed ID: 22221847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the genetics and treatment of von Willebrand disease.
    Federici AB; Mannucci PM
    Curr Opin Pediatr; 2002 Feb; 14(1):23-33. PubMed ID: 11880730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Barthels M; Budde U
    Hamostaseologie; 2005 Nov; 25(4):367-75. PubMed ID: 16395486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.